Results from the Children's Oncology Group phase III trial of a monoclonal antibody against the insulin-like growth factor-1 receptor in patients with newly diagnosed metastatic Ewing sarcoma

Transl Pediatr. 2023 Oct 30;12(10):1916-1919. doi: 10.21037/tp-23-388. Epub 2023 Oct 10.

Author

Angel M Carcaboso^{1

2}

Affiliations

¹ SJD Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, Spain.
² Pediatric Cancer Program, Institut de Recerca Sant Joan de Deu, Barcelona, Spain.

No abstract available

Keywords: Metastatic Ewing sarcoma; clinical trial; ganitumab; insulin-like growth factor-1 receptor (IGF-1R).

Publication types

Editorial
Comment